Nova Financial Statements From 2010 to 2025
| ELXMF Stock | USD 0 0.00 0.00% |
Check Nova Eye financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nova Eye's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nova financial statements analysis is a perfect complement when working with Nova Eye Valuation or Volatility modules.
Nova |
Nova Eye Medical Company Operating Margin Analysis
Nova Eye's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Nova Eye Operating Margin | (0.72) % |
Most of Nova Eye's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Eye Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Nova Eye Medical has an Operating Margin of -0.725%. This is 97.93% lower than that of the Healthcare sector and 98.16% lower than that of the Medical Devices industry. The operating margin for all United States stocks is 86.84% lower than that of the firm.
Nova Eye Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nova Eye's current stock value. Our valuation model uses many indicators to compare Nova Eye value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nova Eye competition to find correlations between indicators driving Nova Eye's intrinsic value. More Info.Nova Eye Medical is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nova Eye's earnings, one of the primary drivers of an investment's value.About Nova Eye Financial Statements
Nova Eye stakeholders use historical fundamental indicators, such as Nova Eye's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nova Eye investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nova Eye's assets and liabilities are reflected in the revenues and expenses on Nova Eye's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nova Eye Medical. Please read more on our technical analysis and fundamental analysis pages.
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia. Nova Eye operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Nova Pink Sheet
Nova Eye financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Eye security.